What is Everest Re Gp's earnings per share (EPS)?

Everest Re Gp (EG) reported diluted earnings per share of $37.80 for fiscal year 2025. This represents a 18.9% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Everest Re Gp Financials

Source SEC Filings (10-K/10-Q) Updated Mar 31, 2026 Currency USD FYE December

This page shows Everest Re Gp (EG) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 18 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI EG FY2025 2026-05-05

Leveraged balance sheet turns modest asset returns into double-digit equity returns, while cash generation swings more than reported profit.

In FY2025, operating cash flow fell to $3.1B even as net income improved, so the earnings rebound was not matched by cash arriving in the door. That matters because FY2024 cash generation was $5.0B and revenue was roughly flat, which points to a business where reported profit can recover before working-capital behavior or investment flows do.

The balance sheet is doing much of the work: with debt-to-equity at 3.0x and return on assets only 2.6% in FY2025, shareholder returns depend on leverage multiplying modest asset profitability. That helps explain why ROE can still reach 10.3% even though cash is only a small slice of a $62.5B asset base.

Per-share recovery also had a capital-allocation assist: buybacks jumped to $797M in FY2025, shrinking the share count by about 5.9%. So EPS improved faster than total earnings, meaning part of the rebound came from dividing profit across fewer shares rather than from stronger underlying cash generation or a full return to FY2023 profitability.

Financial Health Signals

Financial Profile 21/100

Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →

Health score ≠ stock price. This rates the quality of Everest Re Gp's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Growth

Everest Re Gp's revenue grew a modest 1.2% year-over-year to $17.5B. This slow but positive growth earns a score of 49/100.

Leverage

Everest Re Gp has a moderate D/E ratio of 3.04. This balance of debt and equity financing earns a leverage score of 40/100.

Returns

Everest Re Gp's ROE of 10.3% shows moderate profitability relative to equity, earning a score of 38/100. This is up from 9.9% the prior year.

Piotroski F-Score Neutral

5/9

Everest Re Gp passes 5 of 9 financial strength tests. All 4 profitability signals pass (positive income, cash flow, and earnings quality), 1 of 2 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality Cash-Backed

1.93x

For every $1 of reported earnings, Everest Re Gp generates $1.93 in operating cash flow ($3.1B OCF vs $1.6B net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$17.5B

YoY+1.2%

5Y CAGR+12.8%

10Y CAGR+11.9%

Everest Re Gp generated $17.5B in revenue in fiscal year 2025. This represents an increase of 1.2% from the prior year.

EBITDA

N/A

Net Income

$1.6B

YoY+15.9%

5Y CAGR+25.4%

10Y CAGR+5.0%

Everest Re Gp reported $1.6B in net income in fiscal year 2025. This represents an increase of 15.9% from the prior year.

EPS (Diluted)

$37.80

YoY+18.9%

5Y CAGR+24.2%

10Y CAGR+5.5%

Everest Re Gp earned $37.80 per diluted share (EPS) in fiscal year 2025. This represents an increase of 18.9% from the prior year.

Cash & Balance Sheet

Free Cash Flow

N/A

Cash & Debt

$1.3B

YoY-14.9%

5Y CAGR+10.4%

10Y CAGR+16.6%

Everest Re Gp held $1.3B in cash against $0 in long-term debt as of fiscal year 2025.

Dividends Per Share

N/A

Shares Outstanding

40M

YoY-5.9%

5Y CAGR+0.2%

10Y CAGR-0.6%

Everest Re Gp had 40M shares outstanding in fiscal year 2025. This represents a decrease of 5.9% from the prior year.

Margins & Returns

Gross Margin

N/A

Operating Margin

N/A

Net Margin

9.1%

YoY+1.1pp

5Y CAGR+3.7pp

10Y CAGR-8.1pp

Everest Re Gp's net profit margin was 9.1% in fiscal year 2025, showing the share of revenue converted to profit. This is up 1.1 percentage points from the prior year.

Return on Equity

10.3%

YoY+0.4pp

5Y CAGR+5.0pp

10Y CAGR-2.6pp

Everest Re Gp's ROE was 10.3% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 0.4 percentage points from the prior year.

Capital Allocation

R&D Spending

N/A

Share Buybacks

$797.0M

YoY+298.5%

5Y CAGR+31.9%

10Y CAGR+7.1%

Everest Re Gp spent $797.0M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents an increase of 298.5% from the prior year.

Capital Expenditures

N/A

EG Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	$17.5B+1.2%	$17.3B+18.5%	$14.6B+21.0%	$12.1B+1.6%	$11.9B+23.6%	$9.6B
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	N/A	N/A	N/A	N/A	N/A	N/A
Operating Income	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	N/A	N/A	N/A	N/A	N/A	N/A
Income Tax	$296.0M+146.7%	$120.0M+133.1%	-$363.0M-3933.3%	-$9.0M-105.4%	$167.0M+135.2%	$71.0M
Net Income	$1.6B+15.9%	$1.4B-45.5%	$2.5B+321.6%	$597.0M-56.7%	$1.4B+168.3%	$514.0M
EPS (Diluted)	$37.80+18.9%	$31.78-47.2%	$60.19+296.2%	$15.19-56.1%	$34.62+170.9%	$12.78

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Revenue	$4.1B-8.0%	$4.4B+2.4%	$4.3B-3.8%	$4.5B+5.3%	$4.3B-8.0%	$4.6B+8.2%	$4.3B+1.4%	$4.2B
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Income	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	$10.0M	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Income Tax	$83.0M-23.1%	$108.0M+671.4%	$14.0M-89.6%	$135.0M+246.2%	$39.0M+125.2%	-$155.0M-327.9%	$68.0M-37.0%	$108.0M
Net Income	$653.0M+46.4%	$446.0M+74.9%	$255.0M-62.5%	$680.0M+223.8%	$210.0M+135.4%	-$593.0M-216.5%	$509.0M-29.7%	$724.0M
EPS (Diluted)	$16.21	N/A	$6.09-62.2%	$16.10+228.6%	$4.90	N/A	$11.80-29.3%	$16.70

EG Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	$62.5B+11.0%	$56.3B+14.1%	$49.4B+23.6%	$40.0B+4.7%	$38.2B+16.7%	$32.7B
Current Assets	N/A	N/A	N/A	N/A	N/A	N/A
Cash & Equivalents	$1.3B-14.9%	$1.5B+7.8%	$1.4B+2.8%	$1.4B-3.0%	$1.4B+79.7%	$802.0M
Inventory	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$47.1B+10.8%	$42.5B+17.3%	$36.2B+14.8%	$31.5B+12.4%	$28.0B+22.0%	$23.0B
Current Liabilities	N/A	N/A	N/A	N/A	N/A	N/A
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	$15.5B+11.4%	$13.9B+5.1%	$13.2B+56.4%	$8.4B-16.7%	$10.1B+4.2%	$9.7B
Retained Earnings	$16.6B+8.2%	$15.3B+7.3%	$14.3B+18.5%	$12.0B+2.9%	$11.7B+10.7%	$10.6B

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Total Assets	$62.3B-0.3%	$62.5B+0.4%	$62.2B+2.8%	$60.5B+4.1%	$58.1B+3.2%	$56.3B+0.9%	$55.9B+6.3%	$52.6B
Current Assets	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash & Equivalents	$1.4B+7.4%	$1.3B-14.4%	$1.5B-19.1%	$1.9B+21.4%	$1.6B+1.2%	$1.5B-3.1%	$1.6B+1.8%	$1.6B
Inventory	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$47.1B0.0%	$47.1B+0.4%	$46.9B+3.0%	$45.5B+3.4%	$44.0B+3.6%	$42.5B+4.8%	$40.5B+5.6%	$38.4B
Current Liabilities	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	$15.3B-1.1%	$15.5B+0.6%	$15.4B+2.4%	$15.0B+6.2%	$14.1B+1.9%	$13.9B-9.5%	$15.3B+8.1%	$14.2B
Retained Earnings	$17.1B+3.5%	$16.6B+2.2%	$16.2B+1.1%	$16.0B+3.9%	$15.4B+0.8%	$15.3B-4.2%	$16.0B+2.7%	$15.6B

EG Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	$3.1B-38.1%	$5.0B+8.9%	$4.6B+23.2%	$3.7B-3.6%	$3.8B+33.4%	$2.9B
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	-$2.1B+53.2%	-$4.5B+24.1%	-$5.9B-72.7%	-$3.4B+11.7%	-$3.9B-5.1%	-$3.7B
Financing Cash Flow	-$1.2B-206.8%	-$383.0M-127.2%	$1.4B+492.5%	-$359.0M-153.3%	$674.0M-15.8%	$800.0M
Dividends Paid	$335.0M+0.3%	$334.0M+16.0%	$288.0M+12.9%	$255.0M+3.2%	$247.0M-0.8%	$249.0M
Share Buybacks	$797.0M+298.5%	$200.0M	$0-100.0%	$61.0M-72.9%	$225.0M+12.5%	$200.0M

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Operating Cash Flow	$649.0M+263.1%	-$398.0M-127.3%	$1.5B+35.2%	$1.1B+16.3%	$928.0M+19.0%	$780.0M-55.1%	$1.7B+30.0%	$1.3B
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	-$88.0M-113.3%	$663.0M+138.0%	-$1.7B-292.1%	-$445.0M+21.8%	-$569.0M+39.0%	-$933.0M+39.0%	-$1.5B-31.0%	-$1.2B
Financing Cash Flow	-$454.0M+5.8%	-$482.0M-467.1%	-$85.0M+70.1%	-$284.0M+12.3%	-$324.0M-389.3%	$112.0M+158.9%	-$190.0M-25.0%	-$152.0M
Dividends Paid	$80.0M-2.4%	$82.0M-2.4%	$84.0M0.0%	$84.0M-1.2%	$85.0M0.0%	$85.0M-1.2%	$86.0M-1.1%	$87.0M
Share Buybacks	$330.0M-16.9%	$397.0M	$0-100.0%	$200.0M0.0%	$200.0M	$0-100.0%	$100.0M+53.8%	$65.0M

EG Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	9.1%+1.1pp	8.0%-9.3pp	17.3%+12.3pp	5.0%-6.7pp	11.6%+6.3pp	5.4%
Return on Equity	10.3%+0.4pp	9.9%-9.2pp	19.1%+12.0pp	7.1%-6.5pp	13.6%+8.3pp	5.3%
Return on Assets	2.5%+0.1pp	2.4%-2.7pp	5.1%+3.6pp	1.5%-2.1pp	3.6%+2.0pp	1.6%
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A
Debt-to-Equity	3.04-0.0	3.06+0.3	2.74-1.0	3.73+1.0	2.77+0.4	2.36
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	16.1%+6.0pp	10.1%+4.2pp	5.9%-9.2pp	15.1%+10.2pp	4.9%+17.7pp	-12.8%-24.7pp	11.9%-5.3pp	17.1%
Return on Equity	4.3%+1.4pp	2.9%+1.2pp	1.7%-2.9pp	4.5%+3.0pp	1.5%+5.8pp	-4.3%-7.6pp	3.3%-1.8pp	5.1%
Return on Assets	1.1%+0.3pp	0.7%+0.3pp	0.4%-0.7pp	1.1%+0.8pp	0.4%+1.4pp	-1.1%-2.0pp	0.9%-0.5pp	1.4%
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Debt-to-Equity	3.08+0.0	3.040.0	3.05+0.0	3.03-0.1	3.11+0.1	3.06+0.4	2.64-0.1	2.71
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Similar Companies

Reinsurance Grp RGA

$14.0B

Renaissance RNR

$12.6B

Hamilton Insurance Group HG

$3.1B

Siriuspoint Ltd SPNT

$2.7B

Ryan Specialty Hldgs Inc RYAN

$4.2B

Frequently Asked Questions

What is Everest Re Gp's annual revenue?

Everest Re Gp (EG) reported $17.5B in total revenue for fiscal year 2025. This represents a 1.2% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Everest Re Gp's revenue growing?

Everest Re Gp (EG) revenue grew by 1.2% year-over-year, from $17.3B to $17.5B in fiscal year 2025.

Is Everest Re Gp profitable?

Yes, Everest Re Gp (EG) reported a net income of $1.6B in fiscal year 2025, with a net profit margin of 9.1%.

What is Everest Re Gp's net profit margin?

Everest Re Gp (EG) had a net profit margin of 9.1% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is Everest Re Gp's return on equity (ROE)?

Everest Re Gp (EG) has a return on equity of 10.3% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Everest Re Gp's operating cash flow?

Everest Re Gp (EG) generated $3.1B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Everest Re Gp's total assets?

Everest Re Gp (EG) had $62.5B in total assets as of fiscal year 2025, including both current and long-term assets.

Does Everest Re Gp buy back shares?

Yes, Everest Re Gp (EG) spent $797.0M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does Everest Re Gp have outstanding?

Everest Re Gp (EG) had 40M shares outstanding as of fiscal year 2025.

What is Everest Re Gp's debt-to-equity ratio?

Everest Re Gp (EG) had a debt-to-equity ratio of 3.04 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Everest Re Gp's return on assets (ROA)?

Everest Re Gp (EG) had a return on assets of 2.5% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Everest Re Gp's Piotroski F-Score?

Everest Re Gp (EG) has a Piotroski F-Score of 5 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Everest Re Gp's earnings high quality?

Everest Re Gp (EG) has an earnings quality ratio of 1.93x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

How financially healthy is Everest Re Gp?

Everest Re Gp (EG) scores 21 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.